Corticosteroid enhances epithelial barrier function in intestinal organoids derived from patients with Crohn's disease.
Adrenal Cortex Hormones
/ pharmacology
Biomarkers
Cadherins
/ genetics
Cell Line
Cell Membrane Permeability
/ drug effects
Claudins
/ genetics
Crohn Disease
/ drug therapy
Cytokines
/ metabolism
Humans
Inflammation Mediators
/ metabolism
Intercellular Junctions
/ metabolism
Intestinal Mucosa
/ drug effects
Organoids
Prednisolone
/ pharmacology
Signal Transduction
Barrier function
Corticosteroids
Intestinal organoids
Journal
Journal of molecular medicine (Berlin, Germany)
ISSN: 1432-1440
Titre abrégé: J Mol Med (Berl)
Pays: Germany
ID NLM: 9504370
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
11
12
2019
accepted:
20
01
2021
revised:
15
01
2021
pubmed:
13
2
2021
medline:
19
1
2022
entrez:
12
2
2021
Statut:
ppublish
Résumé
Corticosteroids (CS), first-line therapeutics for Crohn's disease (CD) with moderate or severe disease activity, were found to restore intestinal permeability in CD patients, whereas the underlying molecular events are still largely unknown. This study aimed to investigate the effect and mechanisms of CS prednisolone on epithelial barrier using CD patient-derived intestinal organoids. 3D intestinal organoids were generated from colon biopsies of inactive CD patients. To mimic the inflammatory microenvironment, a mixture of cytokines containing TNF-α, IFN-γ, and IL-1β were added to the organoid culture with or without pre-incubation of prednisolone or mifepristone. Epithelial permeability of the organoids was assessed by FITC-D4 flux from the basal to luminal compartment using confocal microscopy. Expression of junctional components were analyzed by qRT-PCR, immunofluorescence staining, and western blot. Activity of signaling pathways were analyzed using western blot. Exposure of the cytokines significantly disrupted epithelial barrier of the intestinal organoids, which was partially restored by prednisolone. On the molecular level, the cytokine mixture resulted in a significant reduction in E-cadherin and ILDR-1, an increase in CLDN-2, MLCK, and STAT1 phosphorylation, whereas prednisolone ameliorated the abovementioned effects induced by the cytokine mixture. This study demonstrates that prednisolone confers a direct effect in tightening the epithelial barrier, identifies novel junctional targets regulated by prednisolone, and underscores intestinal barrier restoration as a potential mechanism that contributes to the clinical efficacy of prednisolone in CD patients. KEY MESSAGES: Prednisolone confers a direct preventive effect against cytokine-induced barrier dysfunction. Prednisolone regulates the expression of CLDN-2, E-cadherin, and ILDR-1. The effect of prednisolone is GR-, MLCK-, and STAT1-dependent.
Identifiants
pubmed: 33575854
doi: 10.1007/s00109-021-02045-7
pii: 10.1007/s00109-021-02045-7
pmc: PMC8164603
doi:
Substances chimiques
Adrenal Cortex Hormones
0
Biomarkers
0
CLDN2 protein, human
0
Cadherins
0
Claudins
0
Cytokines
0
Inflammation Mediators
0
Prednisolone
9PHQ9Y1OLM
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
805-815Références
World J Gastroenterol. 2017 Sep 28;23(36):6628-6638
pubmed: 29085208
Lab Invest. 2008 Oct;88(10):1110-20
pubmed: 18711353
Exp Eye Res. 2008 Jun;86(6):867-78
pubmed: 18501346
Gastroenterology. 2016 May;150(5):1098-1112
pubmed: 26774180
Proteomes. 2018 Mar 31;6(2):
pubmed: 29614738
Int J Mol Med. 2017 May;39(5):1206-1214
pubmed: 28339048
Gut. 2017 Dec;66(12):2193-2195
pubmed: 28159838
Gut. 2007 Jan;56(1):61-72
pubmed: 16822808
Am J Physiol Gastrointest Liver Physiol. 2014 Feb;306(3):G218-28
pubmed: 24309183
Am J Physiol Gastrointest Liver Physiol. 2007 Feb;292(2):G590-8
pubmed: 17068119
Mucosal Immunol. 2014 Jan;7(1):6-19
pubmed: 24084775
Drug Metab Dispos. 2018 Nov;46(11):1572-1580
pubmed: 29615438
FASEB J. 2005 Jun;19(8):923-33
pubmed: 15923402
Am J Pathol. 2005 Feb;166(2):409-19
pubmed: 15681825
Gut. 1999 Jan;44(1):96-100
pubmed: 9862833
Dig Liver Dis. 2001 Nov;33(8):680-5
pubmed: 11785714
Inflamm Bowel Dis. 2001 May;7(2):99-105
pubmed: 11383598
Gastroenterology. 2011 Nov;141(5):1762-72
pubmed: 21889923
Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):9991-5
pubmed: 1279685
World J Gastroenterol. 2014 Feb 7;20(5):1165-79
pubmed: 24574793
Am J Physiol Cell Physiol. 2015 Jul 1;309(1):C38-50
pubmed: 25948735
Nat Rev Immunol. 2014 May;14(5):329-42
pubmed: 24751956
J Surg Res. 2008 Jan;144(1):1-7
pubmed: 17640674
Sci Rep. 2019 Feb 14;9(1):2030
pubmed: 30765731
World J Gastroenterol. 2008 Jan 21;14(3):401-7
pubmed: 18200662
World J Gastroenterol. 2011 Mar 7;17(9):1095-108
pubmed: 21448414
Am J Respir Cell Mol Biol. 1993 Mar;8(3):340-7
pubmed: 8095395
J Biol Chem. 1999 Feb 26;274(9):5443-53
pubmed: 10026156
J Cell Sci. 2013 Feb 15;126(Pt 4):966-77
pubmed: 23239027
Lancet. 2012 Nov 3;380(9853):1590-605
pubmed: 22914295
Gut. 1999 Aug;45(2):191-8
pubmed: 10403730
Cell Physiol Biochem. 2017;41(5):1924-1934
pubmed: 28391269
Exp Eye Res. 2016 Nov;152:10-33
pubmed: 27600171
Ann Intern Med. 1986 Dec;105(6):883-5
pubmed: 3777713
Nat Rev Mol Cell Biol. 2016 Sep;17(9):564-80
pubmed: 27353478
World J Gastroenterol. 2017 Feb 14;23(6):964-975
pubmed: 28246470
J Immunol. 2008 Apr 15;180(8):5653-61
pubmed: 18390750
Lab Invest. 2005 Sep;85(9):1139-62
pubmed: 16007110
Gut. 2009 Aug;58(8):1121-7
pubmed: 19398441
Cell Stem Cell. 2018 Dec 6;23(6):787-793.e6
pubmed: 30526881
Pharm Res. 1993 Aug;10(8):1123-9
pubmed: 8415396
Aliment Pharmacol Ther. 2003 Aug 1;18(3):309-17
pubmed: 12895215
Am J Physiol Cell Physiol. 2002 Mar;282(3):C451-60
pubmed: 11832329
Lab Invest. 2006 Feb;86(2):191-201
pubmed: 16402035
Dig Dis Sci. 2011 Oct;56(10):2802-9
pubmed: 21748286
Am J Physiol Regul Integr Comp Physiol. 2018 Aug 1;315(2):R312-R322
pubmed: 29631364
Gut. 2018 Oct;67(10):1905-1906
pubmed: 29208677
Gastroenterology. 1989 Oct;97(4):927-31
pubmed: 2506103
Gastroenterology. 2006 Oct;131(4):1153-63
pubmed: 17030185
Nat Rev Gastroenterol Hepatol. 2020 Jun;17(6):323-337
pubmed: 32203403
Exp Cell Res. 2002 Feb 1;273(1):1-11
pubmed: 11795941
Gastroenterology. 2005 May;128(5):1258-67
pubmed: 15887109
Am J Hum Genet. 2011 Feb 11;88(2):127-37
pubmed: 21255762
Am J Gastroenterol. 2002 Aug;97(8):2000-4
pubmed: 12190167
J Cell Sci. 2000 Jun;113 ( Pt 11):2085-90
pubmed: 10806119
J Clin Invest. 1996 Jul 15;98(2):572-83
pubmed: 8755670
Biotechnol Genet Eng Rev. 2010;26:117-38
pubmed: 21415878
Stem Cell Res. 2019 Mar;35:101383
pubmed: 30776676
PLoS One. 2015 Mar 09;10(3):e0118792
pubmed: 25751518
Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1672-1677
pubmed: 28137842
Gastroenterol Res Pract. 2016;2016:7374197
pubmed: 27746814